Astera Labs, Inc.
ALAB
$287.48
$43.2217.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.00B | 852.53M | 723.04M | 605.55M | 490.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.00B | 852.53M | 723.04M | 605.55M | 490.47M |
| Cost of Revenue | 240.45M | 207.26M | 177.80M | 148.25M | 118.88M |
| Gross Profit | 760.99M | 645.26M | 545.23M | 457.30M | 371.59M |
| SG&A Expenses | 171.94M | 167.84M | 171.90M | 176.53M | 181.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 777.47M | 679.10M | 616.43M | 563.24M | 512.29M |
| Operating Income | 223.97M | 173.42M | 106.61M | 42.31M | -21.81M |
| Income Before Tax | 269.85M | 218.15M | 149.94M | 85.09M | 20.35M |
| Income Tax Expenses | 2.23M | -981.00K | -48.93M | -15.06M | -21.04M |
| Earnings from Continuing Operations | 267.63 | 219.13 | 198.87 | 100.16 | 41.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 267.63M | 219.13M | 198.87M | 100.16M | 41.39M |
| EBIT | 223.97M | 173.42M | 106.61M | 42.31M | -21.81M |
| EBITDA | 233.39M | 180.25M | 111.57M | 46.65M | -18.15M |
| EPS Basic | 1.59 | 1.31 | 1.20 | 0.61 | 0.25 |
| Normalized Basic EPS | 1.00 | 0.82 | 0.57 | 0.32 | 0.08 |
| EPS Diluted | 1.48 | 1.22 | 1.11 | 0.56 | 0.22 |
| Normalized Diluted EPS | 0.93 | 0.76 | 0.52 | 0.30 | 0.07 |
| Average Basic Shares Outstanding | 673.10M | 665.56M | 655.95M | 645.35M | 635.12M |
| Average Diluted Shares Outstanding | 721.07M | 718.03M | 714.41M | 690.61M | 667.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |